Clinical Trials Insight: 700028425
Latest Information Update: 14 Nov 2007
Price :
$35 *
At a glance
- Drugs TT 223 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Transition Therapeutics
- 14 Nov 2007 New trial record.